Founded in 2021, the biotech Nintx perfectly illustrates the power of the Brazilian science
The company has just opened in Campinas the first private laboratory in Latin America for research on the human intestinal microbiome. As the biotech's core business is the study of the intestinal microbiota, the startup can generate value for both the pharmaceutical and food industries. Proof of that was given recently when the French multinational company Grupo Lactalis sought out the biotech. The world's largest dairy group is interested in using Nintx's Made in Brazil innovation.
To have access to the full content, check us out on LinkedIn.
Comments